Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Pharma Industry News Sun Pharma expands skincare play with $99m Alchemee acquisition from Galderma Sun Pharmaceutical acquires Alchemee from Galderma in a $99.28M deal, gaining iconic acne brands like Proactiv. Find out how this boosts its skincare strategy. bySrinathMarch 8, 2022